Firalis Molecular Precision at NextGen Biomed 2026

Join Firalis Molecular Precision at NextGen Biomed 2026 in London!

Date:  24-25 March 2026

Location: QEII Centre, London, UK

Supporting Research with Multi-Omics and Biomarker Expertise

As a fast-growing CRO specializing in multi-omics and biomarker solutions, Firalis Molecular Precision is excited to participate in NextGen Biomed 2026. This premier event brings together leaders from global pharmaceutical companies, innovative biotech organizations, and academic institutions, all focused on advancing precision medicine, translational research, and next-generation therapies.

Meet Us at Booth #51

Come visit Booth #51, where Firalis Molecular Precision will be joined by fellow Janvier Group Biosciences companies, including Janvier Labs, MimAbs, and RD-Biotech.

Come and see how our multi-omics and biomarker expertise can support your research projects:

• Discuss your research projects and discover how our combined expertise can support your work

• Explore our integrated platforms and multi-omics capabilities in action

• Discuss next steps for your studies and get advice to your research goals

Schedule a Meeting

Don’t miss the chance to speak with our experts and learn how Firalis Molecular Precision can support your research and drug development. We look forward to welcoming you to our booth. If you’d like to schedule a dedicated meeting, please contact our business developers at sales@firalis.com

For more information on the program, speakers, and other details, please visit NextGen Biomed 2026

We look forward to seeing you in London!